TEVA SUBSIDIARY ALSO MAY PAY CLAIMS FOR OPIOID SETTLEMENTS

Pennsylvania’s attorney general says a subsidiary of Teva may soon pay over a billion dollars because of its marketing practices. A.G.  Josh Shapiro says the company, Allergan, sold its generics division, which included its opioid products, to Teva Pharmaceuticals.  Shapiro said in a statement that Allergan downplayed the risk of addiction in its marketing. The announcement comes about a week after Teva Pharmaceuticals reached a more than four-billion-dollar settlement with over a dozen states for its marketing practices.